Naproxen 1000 mg Slow-Release Dosing
A 1000 mg slow-release naproxen tablet should be administered once daily, not every 12 hours. 1
Standard Dosing for Slow-Release Formulation
The FDA-approved dosing for slow-release (controlled-release) naproxen is once daily administration 1. This differs fundamentally from immediate-release formulations, which are typically dosed every 12 hours.
Key Dosing Parameters by Indication:
For Rheumatoid Arthritis, Osteoarthritis, and Ankylosing Spondylitis:
- Standard dose: 250-500 mg twice daily for immediate-release formulations
- Maximum dose can reach 1500 mg/day for limited periods (up to 6 months) when higher anti-inflammatory activity is required 1
- The morning and evening doses do not need to be equal in size 1
For Acute Pain Management:
- Starting dose: 500 mg, followed by 500 mg every 12 hours OR 250 mg every 6-8 hours
- Initial daily dose should not exceed 1250 mg
- Maintenance daily dose should not exceed 1000 mg 1
Pharmacokinetic Rationale
The once-daily dosing of 1000 mg controlled-release naproxen is supported by pharmacokinetic data showing:
- Absorption is dependent on drug release from the tablet matrix, with mean absorption time of 9.2 hours for the 1000 mg controlled-release tablet 2
- Once-daily administration maintains equivalent trough concentrations compared to twice-daily immediate-release formulations 2
- Steady-state plasma concentrations are maintained within narrower limits than with twice-daily conventional naproxen 2
- Total exposure (AUC) is comparable between once-daily controlled-release and twice-daily immediate-release formulations 3
Critical Safety Considerations
Use the lowest effective dose for the shortest duration to minimize cardiovascular and gastrointestinal risks 1.
Dose Adjustments Required For:
- Elderly patients: Lower doses recommended due to increased unbound plasma fraction 1
- Renal impairment: Naproxen is NOT recommended if creatinine clearance < 30 mL/min 1
- Hepatic impairment: Consider lower doses 1
Common Pitfall to Avoid:
Do not confuse controlled-release formulations with immediate-release formulations—they are not bioequivalent and have different pharmacokinetic profiles that affect onset of action 1. A 1000 mg controlled-release tablet given once daily is appropriate, whereas the same total daily dose of immediate-release naproxen would typically be split into 500 mg twice daily.